View Item 

Show simple item record

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice

dc.contributor.authorKarabenick, Rachel Lynnen_US
dc.contributor.authorChen, X.en_US
dc.contributor.authorLeach, P. Tarnen_US
dc.contributor.authorMartin, C. Vanen_US
dc.contributor.authorOhizumi, Y.en_US
dc.contributor.authorKiessel, Christina Lynnen_US
dc.contributor.authorUllrich, Thomasen_US
dc.contributor.authorWoods, James H.en_US
dc.contributor.authorRice, Kenner C.en_US
dc.contributor.authorFantegrossi, William E.en_US
dc.date.accessioned2006-09-11T17:41:23Z
dc.date.available2006-09-11T17:41:23Z
dc.date.issued2004-05en_US
dc.identifier.citationFantegrossi, William E.; Kiessel, Christina Lynn; Leach, P. Tarn; Martin, C. Van; Karabenick, Rachel Lynn; Chen, X.; Ohizumi, Y.; Ullrich, Thomas; Rice, Kenner C.; Woods, James H.; (2004). "Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice." Psychopharmacology 173 (3-4): 270-277. <http://hdl.handle.net/2027.42/46360>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46360
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14740148&dopt=citationen_US
dc.description.abstractNo selective antagonists for the effects of MDMA have yet been identified. The structurally-similar, naturally-occurring plant alkaloid nantenine (9,10-methylenedioxy-1,2 dimethoxyaporphine) may represent such a compound.en_US
dc.format.extent315932 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherHyperthermiaen_US
dc.subject.otherMedicineen_US
dc.subject.otherToxicityen_US
dc.subject.otherNantenineen_US
dc.subject.otherMDMAen_US
dc.titleNantenine: an antagonist of the behavioral and physiological effects of MDMA in miceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, Medical School, University of Michigan, 1301 MSRB III, Ann Arbor, MI, 48109–0632, USAen_US
dc.contributor.affiliationotherDepartment of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578, Aoba, Aramaki, Aoba-ku, Sendai , Japanen_US
dc.contributor.affiliationotherDepartment of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578, Aoba, Aramaki, Aoba-ku, Sendai , Japanen_US
dc.contributor.affiliationotherLaboratory of Medicinal Chemistry, NIDDK, National Institutes of Health, Building 8, Room B1-21, Bethesda, MD, 20892, USAen_US
dc.contributor.affiliationotherLaboratory of Medicinal Chemistry, NIDDK, National Institutes of Health, Building 8, Room B1-21, Bethesda, MD, 20892, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid14740148en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46360/1/213_2003_Article_1741.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s00213-003-1741-2en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2003_Article_1741.pdf
Size:
308.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.